Credit Suisse’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-132
Closed -$35K 4016
2016
Q4
$35K Sell
132
-1,160
-90% -$377K ﹤0.01% 4049
2016
Q3
$512K Sell
1,292
-69
-5% -$28.4K ﹤0.01% 3402
2016
Q2
$471K Buy
1,361
+180
+15% +$129K ﹤0.01% 3457
2016
Q1
$982K Sell
1,181
-14
-1% -$11.1K ﹤0.01% 2739
2015
Q4
$1.25M Buy
1,195
+74
+7% +$74.2K ﹤0.01% 2638
2015
Q3
$879K Sell
1,121
-1,043
-48% -$1.07M ﹤0.01% 2925
2015
Q2
$2.85M Buy
2,164
+703
+48% +$1.13M ﹤0.01% 2253
2015
Q1
$2.97M Buy
1,461
+226
+18% +$491K ﹤0.01% 2070
2014
Q4
$2.38M Buy
+1,235
New +$2.2M ﹤0.01% 2403
2014
Q3
Sell
-125
Closed -$120K 4615
2014
Q2
$120K Sell
125
-24
-16% -$20.6K ﹤0.01% 4504
2014
Q1
$161K Sell
149
-40
-21% -$44.3K ﹤0.01% 4417
2013
Q4
$168K Buy
189
+104
+122% +$89.5K ﹤0.01% 4379
2013
Q3
$96K Buy
85
+1
+1% +$1.18K ﹤0.01% 4113
2013
Q2
$99K Buy
+84
New +$79.9K ﹤0.01% 4017

Other funds holding RGLS